Plasmodium berghei
Plasmodium berghei | |
---|---|
Blood-borne forms | |
Scientific classification | |
Domain: | Eukaryota |
Clade: | Diaphoretickes |
Clade: | SAR |
Clade: | Alveolata |
Phylum: | Apicomplexa |
Class: | Aconoidasida |
Order: | Haemospororida |
Family: | Plasmodiidae |
Genus: | Plasmodium |
Species: | P. berghei
|
Binomial name | |
Plasmodium berghei Vincke & Lips, 1948
| |
Strains | |
Plasmodium berghei is a
Originally, isolated from
Biology
Like all malaria parasites of
Although sexuality is necessary in vivo in P. berghei as normal for most sexual organisms, it is a stark competitive disadvantage in vitro. Sinha et al., 2014 implement both mechanical passaging and competitive assay to demonstrate the advantage of loss of gametocyte production: During mechanical passage successive generations are found to naturally trend toward lower gametocytaemia; and nonsexuals outcompete sexuals rapidly when placed together in vitro.[4]: 575
Immunochemistry
Strains
Some strains produce
- ANKA produces CMM.[2] Martins et al., 2016 find endothelin-1 production is vital to CMM disease progression.[1] Subramaniam et al., 2015 find mice respond to ANKA by increasing BTNL2.[2] Chertow et al., 2015 find arginine metabolism indicative of disease severity.[5][6]
- NK65 notably does not produce CMM.[2] Martins et al., 2016 find NK65 can produce CMM under supplementation of endothelin-1.[2]
See section above for specific molecules' interactions.
Distribution
Plasmodium berghei is found in the forests of
Hosts
Plasmodium berghei was first identified in the thicket rat (
The natural insect host of P. berghei is likely Anopheles dureni, however in laboratory conditions it has also been shown to infect An. stephensi.[citation needed]
Gene interactions
In
They find one improves survival probability:
- APOE)[1]
: 221
Treatment
Some phytochemicals show efficacy against P. berghei. Bankole et al., 2016 find Markhamia tomentosa to be highly effective, comparable to chloroquine, while Monoon longifolium is also significantly effective. They find Trichilia heudelotii to be ineffective.[16]
History
This species was first described by Vincke and Lips in 1948 in the Belgian Congo.[17]
Research
Plasmodium berghei infection of laboratory mouse strains is frequently used in research as a model for human malaria.[18] In the laboratory the natural hosts have been replaced by a number of commercially available laboratory mouse strains, and the mosquito Anopheles stephensi, which is comparatively easily reared and maintained under defined laboratory conditions.
P. berghei is used as a model organism for the investigation of human
In several aspects the pathology caused by P. berghei in mice differs from malaria caused by P. falciparum in humans. In particular, while death from P. falciparum malaria in humans is most frequently caused by the accumulation of
P. berghei can be genetically manipulated in the laboratory using standard
A number of genetically modified P. berghei lines have been generated which express fluorescent reporter proteins such as
P. berghei is used in research programs for development and screening of anti-malarial drugs and for the development of an effective vaccine against malaria.[27]
References
- ^ .
- ^ S2CID 204882296.
- PMID 20941396.
- S2CID 2182486.
- ^ S2CID 209446589.
- ^ S2CID 29927044.
- PMID 29034874.
- ^ S2CID 28322523.
- ^ )
- ^ PMID 25185005.
- ^ OCLC 742299021.
- ^ PMID 23988482.
- ^ NIHMSID615755.
- ^ PMID 26626596.
- ^ PMID 21528701.
- .
- ^ Vincke, I.H. and Lips, M. (1948) Un nouveau plasmodium d'un rongeur sauvage du Congo: Plasmodium berghei n.sp. Annales de la Société Belge de Médecine Tropicale 28, 97-104
- ^ PMID 22319438.
- S2CID 20096737.
- PMID 20663715.
- PMID 22990775.
- S2CID 7230793.
- S2CID 38403613.
- PMID 25359557.
- PMID 16019254.
- S2CID 20812965.
- PMID 22560204.
External links
- General information about (the biology of) P. berghei
- Information about the genome and genes of P. berghei